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1. Introduction 
It is critical to know and apply the best estimate of individuals’ remaining life expectancy in 
many areas of public policy, but this estimate is vital for pension policy in both the public and 
private sectors.  Policy makers and private sector managers need to know with high confidence 
the median years that the newly born are expected to live and how this estimate will change in 
the decades to come. For pension policy, the best estimates of remaining life expectancy at 
retirement are crucial for determining the initial benefit or for pricing retirement income 
products.  With the long-term decrease in age-specific mortality rates – the flip side of life 
expectancy estimates – the long-term increase in life expectancy at a specific age is increasingly 
anchored in public law and private sector contracts (for example, linking qualifying conditions, 
initial benefits, or retirement age to an estimate of life expectancy); in turn, the correct 
estimates are critical for establishing the financial sustainability of public and private sector 
schemes and for developing new retirement products. 
Two main approaches are used to estimate life expectancy: one relies on period life tables, the 
other on cohort life tables. The period approach is simpler, as it uses mortality information 
across all ages for a recent period (e.g., a three-year average) to estimate mortality rates, and 
from these, life expectancy at a specific age. This approach ignores past and likely future 
improvements – i.e., the trend in the reduction of mortality rates and the consequent increase 
in life expectancy. The cohort approach incorporates the expected mortality improvement 
unique to each specific birth cohort, estimating the expected development in mortality rates 
and life expectancies for each birth cohort, by gender. This approach is much more ambitious 
and depends on many more assumptions. For this reason, most countries shy away from 
offering official cohort tables. But even reliable and country-produced official period tables are 
the exception rather than the rule for most countries across the world. Low-income and many 
emerging countries typically rely on United Nations (UN) estimates that are grounded in period 
tables; for projections, they apply a robust cohort-type approach adjusted to typically low-
quality data.5 Thus the differences between the conjectured higher and more reliable cohort 
life expectancies and their lower and biased period estimates are normally unknown. 
This paper is structured as follows. Section 2 presents the conceptual difference between 
period and cohort life expectancy measures and the methodological approach used by the 
authors to quantify it. A brief overview of the different estimation methods used in the 
literature is included. Section 3 presents the authors’ estimates of period and cohort life tables 
                                                          
5 See UN (2017) for the presentation of the methodology used in their most recent 2017 demographic projections to 2100, 
including the patterns of mortality decline (PMD) method.  The latter is a dynamic version of the period table or a simplified 
cohort approach.  A companion technical paper by Gu, Pelletier, and Sawyer (2017) compares the performance of the PMD 
method and the three variants of the modified Lee-Carter (MLC) method as applied to age- and sex-specific death rates (mx) 
from 1950–1955 to 2010–2015 and used to project mx from 2015–2020 to 2095–2100 for 155 countries. Overall, the MLC 
method regardless of its variants generally worked well for countries with good-quality data, whereas the PMD method 
performed better for countries with lower-quality data. Their study suggests that the MLC method produces less stable results 
for future age-sex-specific death rates for countries with relatively low-quality data. 
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and life expectancy at birth and at assumed retirement age of 65 for Portugal and Spain. 
Section 4 broadens the international comparison to official estimates of both period and cohort 
life expectancy for distant past, recent, and future years for Australia, the United Kingdom (UK), 
and the United States (US). These comparisons reveal major differences between estimates of 
period and cohort life expectancy in and between countries and across years that amounts to a 
subsidy rate on benefits of 30 percent and more if the inadequate lower estimate is chosen. 
Section 5 discusses the main implications of these differences, analyzing: the scope of the 
differences in economic terms between individuals; what this means for public pension 
schemes’ financial sustainability and their balancing mechanism; how these differences add to 
the observed heterogeneity of longevity in period life considerations; and how this affects 
recent pension reforms that link life expectancy to scheme parameters. Section 6 summarizes 
the results and implications and proposes a simple way forward. 
2. Differences between period and cohort life expectancy measures: Methodological 
approach 
Life expectancy is the most common statistical measure of the average remaining lifetime an 
individual is expected to live, given his current age, year of birth, sex, and other demographic 
and socioeconomic factors, including education, income, and job (Ayuso, Bravo, and Holzmann 
2017a). Life expectancy is critical in assessing a number of public policies, including pension 
schemes and health care systems. To compute life expectancy, the usual procedure involves 
building an ordinary life table, a tabular statistical tool that summarizes the survival and 
mortality experiences of a population and yields additional understanding about longevity 
prospects. In the past, analytical methods and mortality laws (e.g., De Moivre, Gompertz, 
Makeham, Weibull, logistic) were used to compute life expectancy estimates (Bravo 2007). 
Period life tables represent the mortality risks experienced by the different cohorts of an entire 
population during a single, relatively short period of time, usually no longer than three years. 
The corresponding period life expectancy assumes that the mortality rates observed at a given 
moment in time apply throughout the remainder of a person’s life; i.e., they neglect any future 
expected changes in the longevity prospects of the population. Period life expectancy is purely 
a synthetic longevity measure, artificially engineered, that refers to a hypothetical cohort living 
its entire life according to the mortality rates observed at a single period in time. They are 
useful if one wants to compare trends in mortality by gender, over time, by socioeconomic risk 
factors, within regions of a country, or with other countries, but they do not actually represent 
the longevity prospects of individuals born in a given year. In fact, real individuals age and 
survive/die as members of cohorts experiencing time-changing mortality rates. 
Cohort or generation life tables represent the mortality experienced by a cohort of individuals 
born during a relatively short period of time (typically one year) over the course of their entire 
lifetime. They require age-specific probabilities of death computed using mortality data from 
the cohort only. Although cohort life tables based entirely on observed mortality are quite rare 
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in practice since they require consistent quality data over more than a century, cohort life 
tables based on a combination of past and expected future mortality for the cohort are more 
common, particularly in actuarial practice and population projection exercises. Contrary to 
period life expectancy indicators, cohort life expectancy measures take into account both 
observed and projected longevity improvements for the cohort throughout its remaining 
lifetime and are therefore considered a more appropriate measure of an individual's future 
longevity prospects. 
Denote by 𝑚𝑚𝑥𝑥 (𝑡𝑡) the central death rate at age 𝑥𝑥 in year 𝑡𝑡, and by 𝑞𝑞x (t) the corresponding 1-
year death probability. The complete period life expectancy at age 𝑥𝑥 in year 𝑡𝑡, ?̇?𝑒𝑥𝑥𝑃𝑃(𝑡𝑡), is given by 
?̇?𝑒𝑥𝑥
𝑃𝑃(𝑡𝑡) = 12 + � 𝑛𝑛𝑝𝑝𝑥𝑥𝑃𝑃(𝑡𝑡)𝜔𝜔−𝑥𝑥
𝑛𝑛=1
= 12 + ����1 − 𝑞𝑞𝑥𝑥+𝑗𝑗(𝑡𝑡)�𝑛𝑛−1
𝑗𝑗=0
�
𝜔𝜔−𝑥𝑥
𝑛𝑛=1
 (1) 
where 𝑛𝑛𝑝𝑝𝑥𝑥𝑃𝑃(𝑡𝑡) represents the 𝑛𝑛-year period survival probability for an individual aged 𝑥𝑥 in 
year 𝑡𝑡. Now denote by 𝑛𝑛𝑝𝑝𝑥𝑥𝐶𝐶(𝑡𝑡) the 𝑛𝑛-year cohort survival probability for an individual aged 𝑥𝑥 
in year 𝑡𝑡, i.e., the probability that this individual reaches age 𝑥𝑥 + 𝑛𝑛 in year 𝑡𝑡 + 𝑛𝑛. The 
corresponding complete cohort life expectancy at age 𝑥𝑥 in year 𝑡𝑡, ?̇?𝑒𝑥𝑥𝐶𝐶(𝑡𝑡), is given by 
?̇?𝑒𝑥𝑥
𝐶𝐶(𝑡𝑡) = 12 + � 𝑛𝑛𝑝𝑝𝑥𝑥𝐶𝐶(𝑡𝑡)𝜔𝜔−𝑥𝑥
𝑛𝑛=1
= 12 + ����1 − 𝑞𝑞𝑥𝑥+𝑗𝑗(𝑡𝑡 + 𝑗𝑗)�𝑛𝑛−1
𝑗𝑗=0
�
𝜔𝜔−𝑥𝑥
𝑛𝑛=1
 (2) 
From (1) and (2) it is clear that period life expectancy will only match cohort life expectancy if 
age-specific mortality rates do not change over time. If mortality rates are expected to decline 
(increase) over time, cohort life expectancy will always be higher (lower) than period life 
expectancy. During the last two centuries, the life expectancy frontier of developed countries 
experienced a persistent (almost linear) increase in measured period life expectancy (Oeppen 
and Vaupel 2002). Past trends provide overwhelming evidence to suggest that declines in 
mortality rates are expected to continue in the future, making period life expectancy a 
systematically lagged cohort life expectancy indicator, thus systematically underestimating the 
remaining lifetime of individuals. 
Understanding the relationship between period and cohort life expectancy, quantifying the 
magnitude of the differences, analyzing how this link has been changing over time, and 
identifying its determinants are critical issues for pension design and reform. The objective here 
is to define a measure of the systematic correspondence between period and cohort life 
expectancy and express it in terms of the well-known Lee-Carter (LC) stochastic mortality model 
(Lee and Carter 1992). 
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Define by life expectancy gap, ?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡), the difference between period and cohort life 
expectancy at age 𝑥𝑥 in year 𝑡𝑡, i.e., 
?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡) = ?̇?𝑒𝑥𝑥𝐶𝐶(𝑡𝑡) − ?̇?𝑒𝑥𝑥𝑃𝑃(𝑡𝑡) (3) 
The size of the gap (in years of life) expresses by how much period life expectancy at age 𝑥𝑥 in 
year 𝑡𝑡 differs from the life expectancy of the cohort attaining age 𝑥𝑥 in year 𝑡𝑡. In populations 
experiencing a regular improvement in mortality, the gap will be positive. When positive, the 
gap represents the average extra lifetime a cohort is expected to enjoy as a result of expected 
future mortality declines.6  
To quantify the magnitude of ?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡), period and cohort life expectancy must be estimated. 
Computing period and cohort life expectancy depends on forecasting age-specific mortality 
rates. In recent years, considerable attention has been paid to the development of stochastic 
mortality methods, taking into account its three key dimensions: age, period, and cohort (or 
year of birth). Much of this work emerged from the first and still most widely used age-period 
mortality model – the LC model. This model assumes that the force of mortality has a log-
bilinear structure combining age and period parameters, the latter representing a general 
common time trend in mortality to be modelled using time series methods to produce mortality 
projections and generate prospective life tables. In the original log-bilinear LC model the central 
death rate 𝑚𝑚𝑥𝑥 (𝑡𝑡) is of the form ln𝑚𝑚𝑥𝑥 (𝑡𝑡) = 𝛼𝛼𝑥𝑥 + 𝛽𝛽𝑥𝑥𝑘𝑘𝑡𝑡 (4) 
where 𝛼𝛼𝑥𝑥 denotes the general shape of the mortality schedule, 𝛽𝛽𝑥𝑥 represents the age-specific 
patterns of mortality change, and 𝑘𝑘𝑡𝑡 represents the common time trend. The sign and 
magnitude of 𝛽𝛽𝑥𝑥 determine which mortality rates will be more impacted by a change in 𝑘𝑘𝑡𝑡. To 
forecast mortality rates, the authors assume that vectors 𝛼𝛼𝑥𝑥 and 𝛽𝛽𝑥𝑥 remain constant over time 
and forecast future values of 𝑘𝑘𝑡𝑡 using a standard univariate (random walk with drift) time series 
model. According to this model, the dynamics of 𝑘𝑘𝑡𝑡 follow 
𝑘𝑘𝑡𝑡 = 𝑘𝑘𝑡𝑡−1 + 𝜇𝜇 + 𝜀𝜀𝑡𝑡   with iid  𝜀𝜀𝑡𝑡~𝑁𝑁𝑁𝑁𝑁𝑁(0,𝜎𝜎2) (5) 
The point estimate of the stochastic forecast of the time index at time 𝑡𝑡0 + 𝑠𝑠, given all data 
available up to 𝑡𝑡0, is given by 
                                                          
6 A related concept is that of life expectancy lag, referring to the time required ed to go back from the current 
period to find a cohort with equivalent life expectancy (Goldstein and Wachter 2006). 
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𝐸𝐸�𝑘𝑘𝑡𝑡0+𝑠𝑠|𝑘𝑘1, … , 𝑘𝑘𝑡𝑡0� = 𝑘𝑘𝑡𝑡0 + 𝑠𝑠𝜇𝜇 (6) 
Combining equations (1)-(4), the life expectancy gap at time 𝑡𝑡0 can be expressed in terms of the 
LC model as follows 
?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡0) = � 𝑒𝑒𝑥𝑥𝑝𝑝𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑚𝑚𝑥𝑥+𝑗𝑗(𝑡𝑡0 + 𝑗𝑗)𝑛𝑛−1
𝑗𝑗=0
� − � 𝑒𝑒𝑥𝑥𝑝𝑝
𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑚𝑚𝑥𝑥+𝑗𝑗(𝑡𝑡0)𝑛𝑛−1
𝑗𝑗=0
� 
= � 𝑒𝑒𝑥𝑥𝑝𝑝𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑒𝑒𝑥𝑥𝑝𝑝�𝛼𝛼𝑥𝑥+𝑗𝑗 + 𝛽𝛽𝑥𝑥+𝑗𝑗𝑘𝑘𝑡𝑡0+𝑗𝑗�𝑛𝑛−1
𝑗𝑗=0
� − � 𝑒𝑒𝑥𝑥𝑝𝑝
𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑒𝑒𝑥𝑥𝑝𝑝�𝛼𝛼𝑥𝑥+𝑗𝑗 + 𝛽𝛽𝑥𝑥+𝑗𝑗𝑘𝑘𝑡𝑡0�𝑛𝑛−1
𝑗𝑗=0
� 
(7) 
or, considering the dynamics of 𝑘𝑘𝑡𝑡 given by (5), as 
?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡0) = � 𝑒𝑒𝑥𝑥𝑝𝑝𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑒𝑒𝑥𝑥𝑝𝑝 �𝛼𝛼𝑥𝑥+𝑗𝑗 + 𝛽𝛽𝑥𝑥+𝑗𝑗�𝑘𝑘𝑡𝑡0 + 𝑗𝑗𝜇𝜇��𝑛𝑛−1
𝑗𝑗=0
�
− � 𝑒𝑒𝑥𝑥𝑝𝑝
𝜔𝜔−𝑥𝑥
𝑛𝑛=1
�−�𝑒𝑒𝑥𝑥𝑝𝑝�𝛼𝛼𝑥𝑥+𝑗𝑗 + 𝛽𝛽𝑥𝑥+𝑗𝑗𝑘𝑘𝑡𝑡0�𝑛𝑛−1
𝑗𝑗=0
� 
(8) 
Assuming all the 𝛽𝛽𝑥𝑥+𝑗𝑗’s are positive (as normally observed in empirical studies using this 
model), the life expectancy gap is a decreasing function of the future trajectory of the time 
index 𝑘𝑘𝑡𝑡 which follows, in the case of the random walk with drift model, a straight line as a 
function of the forecast horizon with constant slope 𝜇𝜇.7 
With continuous survival improvements, observed life expectancy gaps are consistently 
positive. However, as shown below, the gap is not constant over time since rates of mortality 
improvement change due to, e.g., age shifts in the profile of mortality decline and/or turning 
points in the long-term trend of mortality. In very particular circumstances (constant yearly 
improvements at all ages within a Gompertz mortality model), linear increases in period life 
expectancy correspond to linear increases in the respective cohort life expectancy (Missov and 
Lenart 2011). 
                                                          
7 For an analytical expression of the quantile function of the period life expectancy in the LC framework see Denuit 
(2007). 
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From equation (8), observe that the magnitude and dynamics of ?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡0) in the LC framework 
are severely constrained by the model assumptions. The model extrapolates past mortality 
trends assuming that the age pattern of mortality decline is constant over time and that the 
overall time trend declines steadily at a constant rate, inducing systematic forecast errors. The 
underestimation of the life expectancy gap becomes larger if a country experiences long-term 
trend changes in mortality, namely acceleration in the rates of mortality decline. Observed 
period and cohort life expectancy increases result from the continuous linear shift from 
younger to older ages in the distribution of mortality reductions. In the future, this will lead to 
an underestimation of the longevity of retired cohorts with an increasing impact on social 
welfare systems. 
The LC model motivated numerous variants and extensions to increase predictive performance. 
Alternative estimation approaches were developed by Lee and Miller (2001), Booth, 
Maindonald, and Smith. (2002), and Brouhns, Denuit, and Vermunt (2002a, 2002b) to provide 
more robust statistical properties (Poisson regression setting and maximum likelihood (ML) 
estimation techniques) and to improve the model’s goodness-of-fit and forecasting 
performance.  
Denton, Feaver, and Spencer (2005) use experimental stochastic methods based on 
nonparametric, partially parametric, and fully parametric approximation as alternatives to the 
LC model to forecast life expectancies using Canadian data. Renshaw and Haberman (2006) 
generalize the LC model by including cohort effects within generalized linear models (GLMs) 
with Poisson error structures. Currie (2006) develops a simplified version of the Renshaw-
Haberman model with independent age, period, and cohort effects. Hyndman and Ullah (2007) 
propose a particular version of the LC model called the Functional Demographic Model (FDM), 
extending the original principal components approach by adopting a functional data paradigm. 
Currie, Durban, and Eilers (2004) develop the P-spline approach, a penalized fitting process 
using basis splines.  
Cairns, Blake, and Dowd (CBD) (2006) assume that the logit of the one-year death probability is 
a linear function of age, and treat the intercept and slope parameters across years as stochastic 
processes. Cairns et al. (2009) investigate three extensions to the original CBD model by 
incorporating combinations of a quadratic age term and a cohort effect term. Plat (2009) 
combines the LC and CBD models to generate a model that produces appropriate mortality 
estimates for all age ranges and is consistent with cohort effects. 
Hunt and Blake (2014, 2015) present a general procedure for constructing mortality models 
that improves the goodness-of-fit of the model parsimoniously and exhibits demographic 
significance. The authors describe an age-period-cohort model structure that encompasses the 
vast majority of previous stochastic mortality models. Currie (2016) shows that many mortality 
models can be expressed in terms of GLMs or generalized nonlinear models (GNLMs). A number 
of papers develop multipopulation mortality modelling (e.g., Li and Lee 2005; Cairns et al. 2011; 
8 
 
Dowd et al. 2011; Jarner and Kryger 2011; Zhu, Tan, and Wang 2017). Others focus on cause-of-
death mortality modelling (e.g., Hanewald 2011; Gourieroux and Lu 2015). Other extrapolative 
approaches use Bayesian modelling, GLMs, and state-space approaches. An extensive review of 
mortality forecasting methods can be found in Bravo (2007), Booth and Tickle (2008), and Blake 
et al. (2017). A most recent and promising estimation approach takes account of the 
accelerating decrease in mortality rates across industrialized countries, particularly at higher 
ages (Palmer, Alho, and Zhao de Gosson de Varennes 2018). Their ex-post and ex-ante 
evaluations against 2600 birth cohort data of eight countries suggest a sizable and rising 
underestimation of cohort life expectancy using existing methods. 
3. Estimating the life expectancy gap for Portugal and Spain 
This section estimates the magnitude of the life expectancy gap in Portugal and Spain. Expected 
future mortality developments are modeled using the log-bilinear LC model under a Poisson 
setting (Brouhns, Denuit, and Vermunt 2002a; Renshaw and Haberman 2003). To calibrate the 
model, data for the overall populations of Portugal and Spain from 1980 to 2015 and for ages 
0–95 are used. Data on deaths and exposures are obtained from the Human Mortality Database 
(2018). Parameter estimates are obtained using ML methods and an iterative method for 
estimating log-bilinear models developed by Goodman (1979), considering the usual 
identification constraints. It is then assumed that the age vectors 𝛼𝛼𝑥𝑥 and 𝛽𝛽𝑥𝑥 remain constant 
over time and future values of 𝑘𝑘𝑡𝑡 are forecasted using a standard univariate time series 
ARIMA(p,d,q) model. Finally, to close the prospective life tables at high ages and to establish 
the highest attainable age ω , the simple and efficient method proposed by Denuit and 
Goderniaux (2005) is applied. Once the matrix of observed and projected mortality rates 𝑞𝑞𝑥𝑥,𝑡𝑡, 
𝑥𝑥 ∈ [𝑥𝑥𝑚𝑚𝑚𝑚𝑛𝑛, 𝑥𝑥𝑚𝑚𝐺𝐺𝑥𝑥], 𝑡𝑡 ∈ [𝑡𝑡𝑚𝑚𝑚𝑚𝑛𝑛, 𝑡𝑡𝑚𝑚𝐺𝐺𝑥𝑥] is generated, complete period and cohort life expectancies 
are computed using (1) and (2). 
The LC parameter estimates (Figure 3.1), the forecasted period and cohort life expectancies 
(Figure 3.2), and the forecasted mortality rates for some representative ages (Figure 3.3) for the 
Portuguese and Spanish female populations are exhibited below. Figure 3.1 shows that the 
general shape of mortality across ages (as represented by the 𝛼𝛼𝑥𝑥 parameter estimates) exhibits 
similar patterns in Portugal and Spain between 1980 to 2015. 
 
9 
 
Figure 3.1. Lee-Carter parameter estimates for the Portuguese (top) and Spanish (bottom) 
female populations 
  
 
Source: Authors’ estimates. 
 
As is common in developed countries, average mortality rates are relatively high for newborns 
and children, then decrease rapidly toward their minimum (around age 12), increasing 
thereafter with age, reflecting higher mortality at older ages. The only minor exception is the 
well-known "mortality hump" around ages 20–25, normally more pronounced in the male 
population, a phenomena normally associated with accident- or suicide-related mortality. 
The time trend parameter estimates 𝑘𝑘𝑡𝑡 exhibit a clear decreasing tendency (approximately 
linear) in both countries, indicating the significant mortality improvements registered for all 
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ages and both sexes over the last 35 years. The rhythm at which mortality improvements have 
taken place is not homogeneous across ages, however, as observed from the 𝛽𝛽𝑥𝑥 parameter 
estimates. Observed mortality improvements have been more significant for youth, particularly 
in Portugal due to better infectious diseases control, better health care systems, and improved 
living conditions, but are also relevant for adults and the elderly. 
The forecasted mortality rates project into the future past trends observed in mortality across 
all ages. Figure 3.2 uses bootstrap simulation methods to derive confidence bands for the 
mortality rates of Portuguese and Spanish female populations aged 0 and 65. As can be 
observed, the Poisson-LC method projects a continued decline in mortality at these ages, with 
increased volatility around the general trend more significant at birth. 
 
Figure 3.2. Forecasted mortality rates and confidence bands for the Portuguese and Spanish 
female populations 
  
Source: Authors’ estimates. 
Figure 3.3 reports period and cohort life expectancies computed at birth and at age 65 for 
Portuguese and Spanish females for the period between 1980 and 2060. In both populations 
the life expectancy gap is significant, with period life expectancy indicators clearly 
underestimating future longevity prospects. The difference is, as expected, more significant at 
birth (13.1 years in 1980 in Portugal and 12.8 years in Spain) than at age 65 (1.7 years in 1980 in 
Portugal and 1.9 years in Spain). 
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Figure 3.3. Period and cohort life expectancies for the Portuguese and Spanish female 
populations 
 
 
Source: Authors’ estimates. 
 
Similar results for ?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡) were obtained for the male populations of both countries. The life 
expectancy gap is expected to continue to be significant in both countries in the future, 
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although the magnitude of ?̇?𝑒𝑥𝑥
𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡) is forecasted to decline at birth and to slightly increase at 
age 65. 
 
4. Period versus cohort life expectancy estimates: International results 
Cohort life expectancies currently exceed period life expectancies due to the observed 
decreases in mortality rates that started in the 18th century in some advanced countries and 
continue in the 21st century worldwide (see Ayuso, Bravo, and Holzmann 2015). As explained in 
the preceding section, period tables are static tables built on the basis of the mortality behavior 
observed in the population during one period, while cohort tables incorporate projections of 
the future trend in mortality, taking into account observed changes over time, at birth and at 
different ages for different generations. The different demographic institutes across countries 
do not construct cohort tables as frequently as they do period tables. In fact, for most 
countries, information on observed and projected life expectancy based on static calculations 
(typically jointly collected for different countries by international organizations such as the UN,8 
the World Bank,9 Eurostat,10 and OECD11) can be found, and is systematically used in 
calculations related to pensions, health, long-term care, and welfare status; on the contrary, it 
is rare to find life expectancy estimates based on cohort tables. 
This section compares the limited comparable country data on period and cohort life 
expectancy that exist from official sources for Australia, the UK, and the US, supplemented by 
the estimates of cohort life expectancy for Portugal and Spain presented above.12  The three 
data points cover the years 1981, 2010, and 2060. The period and cohort life expectancy by sex, 
at birth and at age 65, for these countries and calendar years, and differences between them in 
absolute terms are presented in Table 4.1a, Table 4.2b, Table 4.2a, and Table 4.2b. Differences 
between gender estimates are presented in Table 4.1c and Table 4.2c. The results for the 
analyzed countries at birth and at age 65 are plotted in Figure 4.1 and Figure 4.2, respectively.  
                                                          
8 http://www.un.org/en/development/desa/population/ 
9 http://databank.worldbank.org/data/reports.aspx?source=health-nutrition-and-population-statistics 
10 http://ec.europa.eu/eurostat/web/population-demography-migration-projections/deaths-life-expectancy-
data/database?p_p_id=NavTreeportletprod_WAR_NavTreeportletprod_INSTANCE_OAgLk1BN22Jg&p_p_lifecycle=0&p_p_state
=normal&p_p_mode=view&p_p_col_id=column-2&p_p_col_count=1 
11 http://www.oecd-ilibrary.org/social-issues-migration-health/health-key-tables-from-
oecd_20758480;jsessionid=1pv4a51h45r01.x-oecd-live-03  
12 The period and cohort life expectency estimates for New Zealand and their differences and trends support the analysis.  Their 
results are not included here as the available years do not coincide with this analysis.  For New Zealand estimates, see 
http://archive.stats.govt.nz/browse_for_stats/health/life_expectancy/cohort-life-expectancy.aspx. 
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Table 4.1a. Period and cohort life expectancy at birth: International comparison, by gender 
 1981 2010 2060 
 Period Cohort Period Cohort Period Cohort 
Men 
      UK 70.90 84.60 78.40 89.80 86.70 96.90 
US 70.37 77.78 75.40 80.96 80.18 84.63 
Australia 71.23 86.50 79.75 92.40 88.50 93.00 
Spain 72.52 81.13 79.05 89.94 87.38 95.47 
Portugal 68.30 81.13 76.76 88.33 85.82 94.29 
Women       
UK 76.90 88.30 82.40 92.60 89.30 99.30 
US 77.85 82.40 79.95 84.96 83.93 88.00 
Australia 78.27 89.10 84.21 94.75 90.00 96.00 
Spain 78.78 91.53 85.21 96.07 92.85 100.90 
Portugal 75.43 88.53 83.14 94.41 91.31 99.42 
Source: The UK (Office for National Statistics; 2014-based principal projection life expectancy variant); the US (Life Tables for 
the United States Social Security Area 1900–2100); Australia (PCPOP and ABS 2008, Australian Historical Population Statistics, 
Cat. No. 3105.0.65.001; and ABS (various issues), Life Tables, States, Territories and Australia, Cat. No. 3302055001DO001); 
Spain (Period life expectancies – Instituto Nacional de Estadística INE; Cohort life expectancies – Authors’ estimates); Portugal 
(Period life expectancies – Instituto Nacional de Estatística INE; Cohort life expectancies – Authors’ estimates). 
 
Table 4.1b. Difference in years (absolute value) between cohort and period life expectancy at 
birth: International comparison, by gender 
 
1981 2010 2060 
Men 
      UK 13.70 11.40 10.20 
US 7.41 5.56 4.45 
Australia 15.27 12.65 4.50 
Spain 8.61 10.88 8.10 
Portugal 12.82 11.56 8.47 
Women       
UK 11.40 10.20 10.00 
US 4.55 5.01 4.07 
Australia 10.83 10.54 6.00 
Spain 12.76 10.86 8.05 
Portugal 13.10 11.27 8.11 
Source: Authors’ calculations based on Table 4.1a. 
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Table 4.1c. Comparison between period and cohort life expectancy differences (years) at 
birth, by gender 
 
1981 2010 2060 
 
Cohort-Period Cohort-Period Cohort-Period 
Men–Women       
UK 2.30 1.20 0.20 
US 2.86 0.55 0.38 
Australia 4.44 2.11 -1.50 
Spain -4.15 0.02 0.05 
Portugal -0.28 0.29 0.36 
Source: Authors’ calculations based on Table 4.1b. 
 
Table 4.1a confirms that cohort life expectancy estimates are always greater than those for 
period life expectancy for all compared countries and years. These differences are presented in 
Table 4.1b, with values higher than 10 years for several countries and periods analyzed.  
This is the case for the UK, Australia, and Portugal, which have the greatest differences 
between the two estimates. Differences also exist in the US and Spain, but are less pronounced 
(e.g., in the US, the difference in life expectancy at birth between period and cohort estimates 
in 2010 is about 5.5 years). In all five countries, differences between the two values are 
projected to decrease over time, probably due to the smaller margin expected to improve 
survival probabilities (taking into account the high probabilities already reached in advanced 
ages). 
Differences between countries are also observed by gender (Table 4.1c). In general, greater 
differences are seen between the estimates of period and cohort life expectancy at birth in men 
than in women. Only in Australia is a greater difference projected for women in 2060, a 
phenomenon that also occurred in Portugal and Spain in 1981. However, a reduction in the 
differences between men and women is generally projected over time (except in Spain and 
Portugal, where they remain essentially unchanged), which could be driven by the reduction in 
the gender gap in life expectancy in these countries. 
A similar analysis for life expectancy at age 65 is presented in Table 4.2a, Table 4.2b, and Table 
4.2c. Table 4.2a again shows that estimated life expectancies from cohort tables are higher than 
those obtained from period tables in all five countries. Differences in years are presented in 
Table 4.2b; the biggest values are observed for Australia (up to a 9-year difference in life 
expectancy), followed by the US (up to a 4-year difference). Again, projected values reflect a 
reduction in the (albeit still positive) differences between cohort and period estimates over 
time. 
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Figure 4.1. Period and cohort life expectancy at birth, by gender 
  
  
Australia Period and cohort life expectancy at birth 
 
 
Sources: See Table 4.1a. Note that the figure for Australia was directly reproduced from 
Productivity Commission (2013) An Ageing Australia: Preparing for the Future, Commission 
Research Paper, Canberra, p. 49. 
Analyzing the differences between men and women (Table 4.2c), only small differences 
between genders tend to persist over time. In the UK, the US, and Australia, men show greater 
differences between cohort and period life expectancy estimates at 65 years; the opposite 
result is found in Spain and Portugal, which show slightly higher differences for women. 
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Table 4.2a. Period and cohort life expectancies at age 65: International comparison, by 
gender 
 
1981 2010 2060 
 Period Cohort Period Cohort Period Cohort 
 
(1989 for UK) (1989 for UK) (2014 for UK) (2014 for UK) (2039 for UK) (2039 for UK) 
Men       
UK 13.8 15.3 18.6 21.2 22.3 24.0 
US 14.24 19.43 16.55 20.91 19.45 23.08 
Australia 14.15 26.05 19.10 28.40 25.80 29.80 
Spain 14.66 15.82 18.41 20.12 24.25 25.88 
Portugal 13.40 16.46 17.21 18.90 23.34 24.96 
Women       
UK 17.6 18.9 21.1 23.5 24.2 26.1 
US 18.58 22.02 19.16 23.43 21.93 25.48 
Australia 18.10 28.50 22.10 31.10 28.35 32.30 
Spain 17.99 19.99 22.61 24.86 28.89 31.10 
Portugal 14.37 18.16 20.95 23.13 27.28 29.34 
Source: the UK (Office for National Statistics; 2014 Principal-based principal projection life expectancy variant); the US (Life 
Tables for the United States Social Security Area 1900–2100); Australia (PCPOP and ABS 2008, Australian Historical Population 
Statistics, Cat. No. 3105.0.65.001; and ABS (various issues), Life Tables, States, Territories and Australia, Cat. No. 
3302055001DO001); Spain (Period life expectancies – Instituto Nacional de Estadística INE; Cohort life expectancies – Authors’ 
estimates); Portugal (Period life expectancies – Instituto Nacional de Estatística INE; Cohort life expectancies – Authors’ 
estimates). 
Table 4.2b. Differences in years (absolute value) between period and cohort life expectancy 
at age 65: International comparison, by gender 
 
1981 2010 2060 
 Cohort-Period Cohort-Period Cohort-Period  (1989 for UK) (2014 for UK) (2039 for UK) 
Men 
      UK 1.50 2.60 1.70 
US 5.19 4.36 3.63 
Australia 11.90 9.30 4.00 
Spain 1.16 1.71 1.63 
Portugal 3.06 1.69 1.62 
Women       
UK 1.30 2.40 1.90 
US 3.44 4.27 3.55 
Australia 10.40 9.00 3.95 
Spain 2.00 2.25 2.21 
Portugal 3.79 2.18 2.06 
Source: Authors’ calculations based on Table 4.2a. 
17 
 
Tale 4.2c. Comparison between period and cohort life expectancy differences at age 65, by 
gender 
 
1981 2010 2060 
 
Cohort-Period Cohort-Period Cohort-Period 
Men– Women 
      UK 0.2 0.2 -0.2 
US 1.75 0.09 0.08 
Australia 1.5 0.3 0.05 
Spain -0.84 -0.54 -0.58 
Portugal -0.73 -0.49 -0.44 
Source: Authors’ calculations based on Table 4.2b. 
 
Figure 4.2: Period and cohort life expectancy at age 65, by gender 
  
  
Australia Period and cohort life expectancy at age 65 
 
Source: See Table 4.1a. Note that the figure for Australia was directly reproduced from 
Productivity Commission (2013) An Ageing Australia: Preparing for the Future, Commission 
Research Paper, Canberra, p.49. 
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5. Implications for pension policy  
Applying estimates of remaining life expectancy at retirement by using the lower period life 
expectancy instead of the higher cohort life expectancy has two key implications for pension 
policy. 
First, at the individual level, doing so fails to establish an actuarially fair link between 
contributions and benefits, thus distorting individuals’ labor supply and saving decisions 
(contrary to the goal of recent reform attempts). Assuming that cohort life expectancy is the 
correct estimate, using the lower period life expectancy to calculate the initial benefit implies a 
subsidy for individuals that may not only bias one’s labor supply while young and one’s 
retirement decision when older – it may also affect one’s saving and dis-saving decisions over a 
lifetime. While the bias can go in both directions, the income effect is likely to dominate the 
substitution effect, which may lower one’s labor supply when young and advance the 
retirement age; for saving, one may lower accumulation efforts when young and decumulate 
faster when retired. 
Second, at the pension scheme level, use of the lower period life expectancy makes the pension 
scheme financially unsustainable, as it incorrectly signals solvency; i.e., that liabilities are 
smaller or at most equal to assets, while in reality this is not the case. This is valid for both 
unfunded and funded schemes: in funded schemes, assets are essentially unchanged by an 
underestimation of remaining life expectancy, while liabilities increase. In unfunded 
(nonfinancial) schemes, the contribution asset is negatively affected as it represents the 
present value of the difference between future contributions and the liabilities thereby created; 
if the life expectancies are actually higher, the pay-as-you-go (PAYG) asset must be lower and 
hence both liabilities and assets deteriorate, with liabilities higher and PAYG assets lower than 
assumed. 
Of course, underestimation of actual life expectancy does not remain unnoticed, but emerges 
only gradually in periodic asset/liability checks or more often in the annual cash-flow 
comparison when expenditure due to longer periods of benefit payment exceed contribution 
revenues.  The policy reaction is typically an ad hoc adjustment in nonfinancial defined benefit 
(NDB) schemes’ parameters (such as increasing the contribution rate, playing with the 
indexation parameters of benefits under disbursement, or calling for an increase in the 
retirement age; else the government transfers are increased). In nonfinancial defined 
contribution (NDC) schemes, the key policy options are a lower notional interest rate for the 
annual account accumulation and a lower indexation for benefits in disbursement. In both 
cases, the consequences of systematically underestimated life expectancy are shared in an ad 
hoc manner between the working and retired populations. Such a disruptive approach does not 
create the confidence in the scheme that pension economists consider important for a smooth 
and successful operation. 
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This section explores four policy areas: (a) How important is the difference between period and 
cohort life expectancy for individual decisions and financial sustainability underestimation?; (b) 
What is the effect of the wrong life expectancy choice on the balancing mechanism recently 
implemented in a number of NDB and NDC schemes?; (c) If there is a difference between these 
schemes with regard to the choice of life expectancy estimation, what happens if  
heterogeneity in longevity exists?; and (d) How relevant are life expectancy changes as policy 
triggers after recent reforms? 
5.1. How important is the difference between period and cohort life expectancy 
Section 4 offers the estimated magnitudes between period and cohort life expectancies at birth 
(age 0) and retirement (assumed at age 65).  It is this latter age that matters most for pension 
policy considerations. Table 4.2a and Table 4.2b offer the scope of and differences between 
both approaches.   
These magnitudes and their ratio can be given a simple welfare economic interpretation 
through the concept of pension wealth (see Ayuso, Bravo, and Holzmann 2017b).  Pension 
wealth at any age is the present value of future benefit streams at this age. Assuming that the 
benefit indexation equals the discount rate (an assumption that broadly holds for wage-indexed 
pensions), then pension wealth at retirement is the pension benefit at retirement multiplied by 
life expectancy. If the scheme is actuarially fair, accumulation at retirement should equal 
pension wealth; i.e., the devisor of the accumulation needs to be the correct life expectancy. 
𝑃𝑃𝑃𝑃65(𝑡𝑡) = 𝑏𝑏65(𝑡𝑡) ∙ ?̇?𝑒65(𝑡𝑡) (9) 
𝑏𝑏65(𝑡𝑡) = 𝐴𝐴𝐴𝐴65(𝑡𝑡)/?̇?𝑒65(𝑡𝑡) (10) 
𝑃𝑃𝑃𝑃65(𝑡𝑡) = 𝐴𝐴𝐴𝐴65(𝑡𝑡) for an actuarially fair scheme (11) 
where 𝑃𝑃𝑃𝑃65(𝑡𝑡) is pension wealth, 𝑒𝑒65(𝑡𝑡) life expectancy, 𝐴𝐴𝐴𝐴65(𝑡𝑡) accumulated contributions 
(plus interest), and 𝑏𝑏65(𝑡𝑡) initial pension benefit, all at retirement age 65 in year 𝑡𝑡. 
If the initial benefit is calculated by using the too-low period life expectancy (PLE), then actual 
pension wealth exceeds the value of the accumulation by the ratio of the cohort life expectancy 
(CLE) to the PLE. Expressing the ratio as a change in the difference amounts to a subsidy that 
the generation would receive (unless corrective actions were undertaken). 
Subsidy rate =  𝑃𝑃𝑃𝑃65[𝐶𝐶𝐶𝐶𝐸𝐸]
𝑃𝑃𝑃𝑃65[𝑃𝑃𝐶𝐶𝐸𝐸] −  1 = �
𝐴𝐴𝐴𝐴65
?̇?𝑒65
𝑃𝑃 � × ?̇?𝑒65𝐶𝐶
�
𝐴𝐴𝐴𝐴65
?̇?𝑒65
𝑃𝑃 � × ?̇?𝑒65𝑃𝑃 − 1  = ?̇?𝑒65𝐶𝐶?̇?𝑒65𝑃𝑃   −  1 (12) 
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From Table 4.2b, one can calculate the implicit subsidy rate at retirement that is behind the 
differences between period and cohort life expectancy for the five countries and the three 
years of estimation (Table 5.1).  The reason this can be called a subsidy rate is very simple:  this 
is the rate at which own accumulations would need to increase to achieve the same benefit 
level as that derived from applying the period life expectancy rate to own accumulations. 
Table 5.1. Implicit subsidy rates of applying period over cohort life expectancy  
at age 65 in select countries, by gender 
 
1981 2010 2060 
Men 
   UK 10.9% 14.0% 7.6% 
US 36.4% 26.3% 18.7% 
Australia 84.1% 48.7% 15.5% 
Spain 7.9% 9.3% 6.7% 
Portugal 22.8% 9.8% 6.9% 
Average 32.4% 21.6% 11.1% 
 
Women 
   UK 7.4% 11.4% 7.9% 
US 18.5% 22.3% 16.2% 
Australia 57.5% 40.7% 13.9% 
Spain 11.1% 10.0% 7.6% 
Portugal 26.4% 10.4% 7.6% 
Average 24.2% 18.9% 10.6% 
    
Source: Authors’ calculations based on Table 4.2a. 
Table 5.1 indicates both major differences and commonalities in the implicit subsidy rate 
between countries for which both period and cohort life expectancies are available. First, all 
countries have a declining subsidy rate and thus a shrinking relative gap between period and 
cohort life expectancy over time. While for the age cohort of 1981 the average difference is 32 
percent for men and 24 percent for women, the difference is projected to reduce to slightly 
above 10 percent for both genders for the age cohort of 2060. Second, the differences between 
genders are reduced across 1981, 2010, and 2060 for Australia, the UK, and the US; in Portugal 
and Spain they remain broadly constant. Third, the differences between countries are also 
reduced. While the differences in 1981 between the highest and lowest country value were 
about 10:1, this ratio reduces to 2:1 in 2060. 
It is not clear the extent to which these reduced differences are related to the application of 
similar or common estimation models or if these common trends actually constitute common 
underlying developments.  In any case the scopes are relevant, and comparable in magnitude to 
the heterogeneity created by differences in lifetime income (see section 4).  For the current 
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mid-career generation of 1981 or the current primary school generation of 2010, the subsidy 
created by applying period instead of cohort life expectancy is sizable and may distort their 
labor supply and saving decisions, working against the objectives of recent systemic and 
comprehensive parametric reforms in these five countries.  
5.2. The balancing mechanism in defined benefit and defined contribution schemes 
Most advanced and some emerging economies undertook systemic or comprehensive 
parametric reforms with the objective of making their pension system financially sustainable (or 
more specifically, their main earnings-related pension scheme(s)). To deal with future financial 
disequilibria, various countries introduced a balancing mechanism – i.e., a rule-bound 
mechanism of parametric adjustments to the scheme that is triggered when financial 
disequilibria emerge.13 The adjustment may be in the level of benefit indexation, a reduction in 
the nominal benefit level, a decrease in the annual accrual rate (in NDB schemes), or a change 
in the annual account indexation rate (in NDC schemes). What triggers the application of the 
balancing mechanism may simply be differences in expenditure and revenues of the scheme, or 
some measure of an actuarial imbalance based on the present value of deficits, or very rarely 
the application of more elaborate asset/liability comparisons. To establish financial (un-) 
soundness, some countries undertake annual or periodic actuarial assessments (such as Japan, 
Sweden, the UK, and the US). 
How are these balancing mechanisms influenced if the “wrong” mortality/life expectancy data 
are selected? What is the scope of underestimated liabilities? Are assets also affected? Is there 
a difference between benefit type (DB/DC) and funding mechanism? These issues are discussed 
next in turn. 
The scope of underestimated liabilities: For many policy makers and pension observers, this is 
quite likely the key question, as the size of underestimation of liabilities may determine the 
speed and type of corrective interventions. A full reply is, of course, country specific but the 
results of Table 5.1 suggest the magnitude. The birth cohort of 1981 (i.e., the cohort of those 
currently 37 years old) can be taken as the low boundary estimate for the current generation.  If 
correct and without taking into account future corrective interventions, the subsidy rates can 
proxy the difference between liabilities estimated with cohort mortality rates/life expectancy 
and with the corresponding period estimates. The difference in the all-country average is well 
above 20 percent; for Australia, it is well above 50 percent; and for Spain, it is surprisingly low, 
at about 10 percent.  
                                                          
13 A number of countries introduced balancing mechanisms to assure or at least support financial sustainability of the 
mandated schemes. Some are, in principle, automated through the move toward an NDC scheme and the choice of the account 
indexation rate (such as in Italy, Latvia, Norway, Poland, and Sweden), with only the latter country actually having a formal 
balancing mechanism. A number of NDB countries (e.g., Finland, Germany, Japan, Portugal, and Spain) introduced sustainability 
factors to the same end (see OECD 2012, 2015, and 2017).  However, an assessment of their actual working and effectiveness is 
still outstanding. 
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Clearly, the scope of underestimation of the true liabilities can be sizable, but the implications 
depend on the country and its scheme. In the US, the 30 percent underestimation is likely to 
prevent the adjustment mechanism established by the social security law from kicking in. As 
this scheme has a sizable trust fund that is running down, the policy reaction may only occur 
when the trust fund resources are closer to expiration (currently foreseen by 2034; see Board 
of Trustees 2017). In Australia, there are no direct consequences. Its earnings-related scheme is 
funded and does not provide any annuity at all, nor is its purchase required, and purchase of 
voluntary life annuities is minimal. If individuals underestimate their remaining life expectancy 
and decumulate too fast, the consequences will be realized in the universal old-age pension, 
which is means- and asset-tested but accessed by some two-thirds of the eligible older 
population.  In Spain, the (small) underestimation is only gradually felt by the cash-flow gap as 
no actuarial estimation reprocess and trigger is established. 
The differences between DB/DC and funded/unfunded schemes:  In the typical Bismarckian NDB 
schemes that still dominate much of the world, the differences between period and cohort life 
expectancy have little importance even if periodic actuarial assessments are undertaken. In 
almost all cases, it is the cash balance outcome (i.e., the difference between period revenue 
and period expenditure) that triggers actions (with or without a balancing mechanism in place).  
Actuarial assessments with the too-low life expectancy data may trigger a late and insufficient 
reform when the actual insolvency has already existed for some time. And actuarial 
assessments of NDB schemes are typically built on discounted cash balance approaches, not on 
asset/liability comparisons. Conceptually, NDB schemes may give rise to the largest 
underestimation of actual liabilities, because they underestimate not only the liabilities of those 
already retired, but also those of active contributors. These estimates also rely on using the 
correct mortality data. 
This differs from the liability estimates in NDC schemes, in which liabilities for the active 
workforce are covered by their accumulated contributions, and assets and liabilities fully 
match.  In the estimation of implicit pension debt, liabilities toward active workers typically 
amount to two-thirds of overall liabilities (Holzmann, Palacios, and Zviniene 2001).  Hence the 
underestimation of liabilities in NDC schemes applies only for pensions in disbursement and the 
applied too-low life expectancy when converting individual accumulations into the initial 
pension benefit, and amounts to only one-third of the full liability. However, compared to 
financial defined contribution (FDC) schemes where the assets are – in principle – immune to 
mortality rate misestimation, the wrong choice of mortality rates/life expectancy estimates 
should impact assets in NDC schemes.  This is due to the PAYG asset, which is calculated as the 
present value of future contributions minus the liabilities created; the latter depend, of course, 
on the selected mortality/life expectancy estimates. Applying the too-low period life 
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expectancy estimates underestimates these future liabilities and thus overestimates the PAYG 
asset.14 
For FDB and FDC schemes, typically periodic and often annual actuarial assessments take place.  
While assets are – in principle – immune to the selected mortality estimates, liabilities are 
affected by the incorrect selection, and the scope of this underestimation has been hinted 
above. In funded schemes, however, additional underestimation of the liability may take place 
through the choice of a too-high discount rate. Sometimes the choice of the discount rate is 
determined by the return of the asset side of the funded scheme, for which highly optimistic 
assumptions are assumed. For most pension economists, there is no link to the rate of return as 
the discount rate is governed by other considerations. 
5.3. Adding heterogeneity considerations to estimation of life expectancy 
For pension schemes the issue of correct estimation of future life expectancy of a retiree cohort 
is complicated by the increasing recognition that this mean estimate has a dispersion that is 
linked to the level of lifetime income and accumulated savings (Ayuso, Bravo, and Holzmann 
2017a, 2017b).  Hence, not taking account of both issues may lead to multiple and interrelated 
distortions at both the individual and scheme level. 
For example, the wrong mean estimate for life expectancy leads to underestimation of the 
pension scheme’s liability. If the same common life expectancy is applied to all cohort members 
at retirement, a second underestimation of the liability is introduced, as richer individuals have 
a higher life expectancy. For the highest income decile, the individual subsidy rate may reach 30 
percent for women and 15 percent for men. In contrast, those in the lowest income decile may 
face a tax rate of 20 percent or more on a much lower pension. The scope of the aggregate 
underestimation of liabilities will depend on the distributive characteristics and choice of the 
mean value (average or median), but is hypothesized to be 10–15 percent. 
The interaction of both effects on individuals and their labor supply and saving decisions has 
not yet been worked out. For lower-income groups, the tax rate effect of heterogeneity is 
counteracted by an incorrect lower mean value. For higher-income groups, the subsidy effect of 
heterogeneity is fortified by the subsidy effect of a too-low mean estimate. How this affects 
individuals’ decisions will also depend on their perceptions of their own life expectancy. 
Understanding these mechanisms is important for designing appropriate policy interventions. 
For correct mean and heterogeneity estimates, the effectiveness of some policy proposals has 
already been estimated (Holzmann et al. 2017). 
                                                          
14 In reality, of all the NDC countries only Sweden has a formal (automatic) balancing mechanism and it approximates the PAYG 
asset from cross-sectional revenue data.  Hence, underestimation of life expectancy will also affect its NDC scheme as the PAYG 
asset will tend to be overestimated.   
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5.4. Life expectancy measures in recent pension reforms 
In recent decades, most OECD countries responded to continuous growth in life expectancy 
with pension reforms in which a common feature is to create an automatic link between future 
pensions and changes in life expectancy. The link between life expectancy and pension benefits 
has been accomplished in at least six different ways (Whitehouse 2007; OECD 2017):  
(a) By introducing FDC plans as a (often partial) replacement for unreformed NDB pensions 
(e.g., Mexico, Poland, Sweden);  
(b) By introducing an automatic link between life expectancy and pension benefits, for 
example through demographic sustainability factors (e.g., Finland, Portugal, Spain);  
(c) By linking the normal retirement age to life expectancy (so far 10 countries including 
Denmark, Italy, the Netherlands, and Portugal);  
(d) By connecting years of contributions needed for a full pension to life expectancy (e.g., 
France);  
(e) By substituting traditional NDB public schemes with NDC schemes that replicate some of 
the features of FDC plans, namely the way in which pension (annuity) benefits are 
computed (e.g., Sweden, Poland, Latvia, Italy, Norway);  
(f) By linking penalties (bonuses) for early (late) retirement to years of contributions and 
normal retirement age (e.g., Portugal).  
These reforms represent a fundamental change in the way longevity risk is shared between 
contributors and retirees, and between current and future generations, that has become more 
explicit and, in principle, based on automatic rules rather than ad hoc changes as in the past. 
However, the legislated automaticity in countries must still stand the test of time.  And even if 
automatically introduced and moving in the right direction, these measures are almost always 
incomplete and insufficient to assure financial sustainability issues triggered by life expectancy 
changes. This adds to issues of not selecting the correct life expectancy under these 
mechanisms and the incentive distortions involved. 
In almost all cases and countries, the period life expectancy measure has been used to link 
longevity and pension benefits, which, as discussed above, results in underestimating remaining 
lifetime at retirement. This option has consequences on the way longevity risk is shared 
between generations. The financial consequences of underestimating life expectancy during 
retirement are ultimately borne by those who fund the pension scheme; i.e., younger cohorts in 
NDB/NDC schemes and private contributors/sponsors in FDB/FDC schemes. 
For instance, demographic sustainability factors introduced in Finland, Portugal, and Spain 
automatically link initial pension benefits to life expectancy observed at the time of retirement, 
leading, in most cases, to a reduction in pension entitlements. These sustainability factors are 
computed as a simple ratio between period life expectancy observed at some reference age 
(e.g., 65 in Portugal and 67 in Spain) in some (past) reference year (e.g., 2000 in Portugal and 
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2012 in Spain) and period life expectancy observed at the time of retirement (in Spain 
according to mortality tables for the pensioner population as they are designed by the social 
security system). By design, these sustainability factors are not consistent with an actuarially 
neutral pension scheme since they do not guarantee that by adjusting (reducing) initial pension 
benefits but paying them for a longer period the scheme is financially neutral. To the extent 
that trends in period and cohort life expectancies differ between past and current generations, 
the system could redistribute in favor of older cohorts and have a negative impact on the public 
pension system’s sustainability. 
Linking the normal retirement age to period life expectancy instead of cohort life expectancy 
will extend working lives but will be insufficient to preserve actuarial neutrality between 
contributions and benefits, thus maintaining major distortions in individual labor supply and 
saving decisions, and forgoing the macroeconomic impact of higher levels of employment on 
investment, gross domestic product, consumption, and public finances. Moreover, the lower-
than-consistent-with-actuarial-neutrality increase in the retirement age reduces the size of the 
positive effect on pension adequacy resulting from longer contribution careers and higher 
pension accruals. 
Linking penalties (bonuses) for early (late) retirement to years of contributions and normal 
retirement age using period life expectancy measures does not ensure actuarial neutrality 
between contributions and benefits. Actuarial neutrality depends on the parameters that 
determine the annuity factor – survival probabilities, indexation rate, discount rate – that revert 
to life expectancy when the indexation rate equals the discount rate. Increases in life 
expectancy require higher penalties for early retirement and lower bonuses for late retirement 
to keep up with actuarial neutrality. Adopting a period approach in measuring life expectancy 
to assess the work incentives around retirement ages systematically underestimates the 
magnitude of the penalties (bonuses) for early (late) retirement needed to ensure actuarial 
neutrality and a fair share of longevity risk between generations, and is likely to reduce labor 
supply. 
6. Conclusions and next steps 
While the general discussion about the change in life expectancy of the population and its past 
and projected future increases has finally reached policy makers and the public at large, more 
technical and political attention is needed on the selection of estimates of life expectancy and 
their application. This paper substantiates why it is so important to get life expectancy 
estimates right for pension policy, how it can be done, and how to overcome the key obstacles. 
At the technical level, few arguments arise for not estimating and applying cohort life 
expectancies that take account of past and expected future declines in mortality rates.  
Technical issues remain regarding how best to estimate cohort values, and the best methods 
depend on high-quality data. But even for countries with excellent data quality, estimates 
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seemingly differ across groups of countries. Some recent methods that take account of the 
acceleration in the decrease in mortality rates, particularly at higher ages, suggest a noticeable 
and rising underestimation of cohort life expectancy by conventional methods. Yet the 
potential estimation errors that may emerge from a commonly applied approach (e.g., across 
the European Union) are likely to be dwarfed by the magnitude of the differences generated 
between the cohort and period approaches. 
The paper presents estimates of such differences for five countries: three have official 
estimates of both cohort and period life expectancy (Australia, the UK, and the US), while two 
have only official period tables, supplemented by cohort values estimated herein (Portugal and 
Spain). Significant differences are estimated between cohort and period life expectancies: 
differences reach 8–15 years at birth that are reduced to 2–4 years at age 65, and all projected 
differences tend to decrease over time but do not disappear. Differences in estimated life 
expectancies by gender are also found but are mostly moderate and are not systematic across 
countries or over time. 
Translating these differences in life expectancy at age 65 (around the median age of current 
standard retirement age) amounts to an implicit subsidy to the average retiree that can reach 
30 percent or more of the pension wealth of the current working generation in some countries. 
That is, using period life expectancy to calculate the initial benefit at retirement offers a too-
generous benefit level that is not consistent with actual financial sustainability. To address the 
implications at a later stage will require additional contributions or budget transfers by future 
working generations or a partial default for those currently working (i.e., future retirees). 
Selection of the correct life expectancy estimate is also increasingly important for day-to-day 
pension policy. Most countries have undertaken some kind of reform that legally links pension 
schemes to the development of the officially measured change in life expectancy. This naturally 
includes NDC countries and calculation of the initial benefit, but also includes the many NDB 
countries that have linked benefit levels and/or retirement ages to such a life expectancy 
measure, and the fewer countries that have a financial stability mechanism for their pension 
scheme. In all cases, inadequate choice of the life expectancy measure leads to incentive 
distortions and miscalculations of financial sustainability. 
The proposed solution is simple as well as effective: convince governments that it is in their 
interest to apply the best estimates of cohort life expectancies. The estimation can be 
performed by national statistical offices in close cooperation with academic and partner 
institutions in other countries to compare, to learn, and to progress.   
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